Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    November 2018
  1. GYLLENBERG FK, Saloranta TH, But A, Gissler M, et al
    Induced Abortion in a Population Entitled to Free-of-Charge Long-Acting Reversible Contraception.
    Obstet Gynecol. 2018 Nov 5. doi: 10.1097/AOG.0000000000002966.
    PubMed     Text format     Abstract available


    August 2018
  2. MONTAGUE M, Ascha M, Wilkinson B, Verbus E, et al
    Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002803.
    PubMed     Text format     Abstract available


  3. WU J, Zhang J, Mitra M, Parish SL, et al
    Provision of Moderately and Highly Effective Reversible Contraception to Insured Women With Intellectual and Developmental Disabilities.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002777.
    PubMed     Text format     Abstract available


  4. HILLARD PJA
    Contraception for Women With Intellectual and Developmental Disabilities: Reproductive Justice.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002814.
    PubMed     Text format    


    July 2018
  5. ROTTENSTREICH A, Bauman D, Kalish Y
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018;132:216-217.
    PubMed     Text format    


    May 2018

  6. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:e130-e139.
    PubMed     Text format     Abstract available



  7. ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:947-948.
    PubMed     Text format     Abstract available


    April 2018
  8. BATRA P, Rafie S, Zhang Z, Singh AV, et al
    An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002572.
    PubMed     Text format     Abstract available


    March 2018
  9. BONNINGTON A, Autry AM
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018 Mar 8. doi: 10.1097/AOG.0000000000002518.
    PubMed     Text format     Abstract available


    February 2018
  10. EVANS ML, Espey E, Ogburn T, Zite NB, et al
    Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002489.
    PubMed     Text format     Abstract available


    January 2018
  11. BRANDI K, Morgan JR, Paasche-Orlow MK, Perkins RB, et al
    Obstetric Outcomes After Failed Hysteroscopic and Laparoscopic Sterilization Procedures.
    Obstet Gynecol. 2018 Jan 9. doi: 10.1097/AOG.0000000000002446.
    PubMed     Text format     Abstract available


  12. STUART GS, Ramesh SS
    Interval Female Sterilization.
    Obstet Gynecol. 2018;131:117-124.
    PubMed     Text format     Abstract available


    December 2017
  13. PAL N, Broaddus RR, Urbauer DL, Balakrishnan N, et al
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
    Obstet Gynecol. 2017 Dec 4. doi: 10.1097/AOG.0000000000002390.
    PubMed     Text format     Abstract available


    November 2017
  14. BIGGS MA, Taylor D, Upadhyay UD
    Role of Insurance Coverage in Contraceptive Use After Abortion.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002361.
    PubMed     Text format     Abstract available


  15. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    PubMed     Text format     Abstract available



  16. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:e251-e269.
    PubMed     Text format     Abstract available



  17. Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:1173-1175.
    PubMed     Text format     Abstract available


    October 2017
  18. MONIZ MH, Gavin LE, Dalton VK
    Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002314.
    PubMed     Text format     Abstract available


  19. MENKE MN, King WC, White GE, Gosman GG, et al
    Contraception and Conception After Bariatric Surgery.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002323.
    PubMed     Text format     Abstract available


    September 2017
  20. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Text format     Abstract available


  21. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Text format     Abstract available


    August 2017
  22. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Text format     Abstract available



  23. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Text format     Abstract available



  24. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Text format     Abstract available


    July 2017
  25. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Text format     Abstract available



  26. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Text format     Abstract available



  27. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


    June 2017
  28. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Text format     Abstract available


  29. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Text format     Abstract available


  30. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed     Text format    


    May 2017
  31. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Text format     Abstract available



  32. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Text format     Abstract available



  33. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Text format     Abstract available


  34. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed     Text format    


    April 2017
  35. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed     Text format    


  36. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Text format     Abstract available



  37. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Text format     Abstract available



  38. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Text format     Abstract available


    March 2017
  39. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Text format     Abstract available


  40. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Text format     Abstract available


    February 2017
  41. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Text format     Abstract available


    January 2017
  42. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Text format     Abstract available


  43. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Text format     Abstract available



  44. Clinical Updates in Women's Health Care Summary: Liver Disease: Reproductive Considerations.
    Obstet Gynecol. 2017;129:236.
    PubMed     Text format     Abstract available


    December 2016
  45. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  46. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  47. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  48. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  49. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    August 2016

  50. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed     Text format    



  51. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Text format     Abstract available



  52. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Text format     Abstract available


    May 2016
  53. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: